Cannabinoid 1 receptors in keratinocytes modulate proinflammatory chemokine secretion and attenuate contact allergic inflammation

Journal of Immunology

Volumn 190, Issue 10, 2013, Pages 4929-4936

  Gaffal, Evelyn ^a   Cron, Mira ^a   Glodde, Nicole ^a   Bald, Tobias ^a   Kuner, Rohini ^b   Zimmer, Andreas ^c   Lutz, Beat ^d   Tüting, Thomas ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF BONN   (Germany)

^d UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

1 FLUORO 2,4 DINITROBENZENE; CANNABINOID 1 RECEPTOR; CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MONOCYTE CHEMOTACTIC PROTEIN 2;

ACANTHOSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FLOW CYTOMETRY; GENE TARGETING; IMMUNOCOMPETENT CELL; IN VITRO STUDY; IN VIVO STUDY; KERATINOCYTE; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN ALLERGY;

ADOPTIVE TRANSFER; ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; CHEMOKINE CCL8; CHEMOKINE CXCL10; DERMATITIS, ALLERGIC CONTACT; DINITROFLUOROBENZENE; EAR; INFLAMMATION; INTERFERON-GAMMA; KERATINOCYTES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTOR, CANNABINOID, CB1;

EID: 84877820530     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1201777     Document Type: Article

References (37)

1. Albanesi, C., C. Scarponi, M. L. Giustizieri, and G. Girolomoni. 2005. Keratinocytes in inflammatory skin diseases. Curr. Drug Targets Inflamm. Allergy 4: 329-334. (Pubitemid 40873120)
2. Wittmann, M., and T. Werfel. 2006. Interaction of keratinocytes with infiltrating lymphocytes in allergic eczematous skin diseases. Curr. Opin. Allergy Clin. Immunol. 6: 329-334. (Pubitemid 44368238)
3. Nestle, F. O., P. Di Meglio, J. Z. Qin, and B. J. Nickoloff. 2009. Skin immune sentinels in health and disease. Nat. Rev. Immunol. 9: 679-691.
4. Martin, S. F., and T. Jakob. 2008. From innate to adaptive immune responses in contact hypersensitivity. Curr. Opin. Allergy Clin. Immunol. 8: 289-293.
5. Engeman, T., A. V. Gorbachev, D. D. Kish, and R. L. Fairchild. 2004. The intensity of neutrophil infiltration controls the number of antigen-primed CD8 T cells recruited into cutaneous antigen challenge sites. J. Leukoc. Biol. 76: 941-949. (Pubitemid 39458706)
6. Kish, D. D., N. Volokh, W. M. Baldwin, III, and R. L. Fairchild. 2011. Hapten application to the skin induces an inflammatory program directing haptenprimed effector CD8 T cell interaction with hapten-presenting endothelial cells. J. Immunol. 186: 2117-2126.
7. Gober, M. D., and A. A. Gaspari. 2008. Allergic contact dermatitis. Curr. Dir. Autoimmun. 10:1-26.
8. Maresz, K., G. Pryce, E. D. Ponomarev, G. Marsicano, J. L. Croxford, L. P. Shriver, C. Ledent, X. Cheng, E. J. Carrier, M. K. Mann, et al. 2007. Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells. Nat. Med. 13: 492-497. (Pubitemid 46559830)
9. Massa, F., G. Marsicano, H. Hermann, A. Cannich, K. Monory, B. F. Cravatt, G. L. Ferri, A. Sibaev, M. Storr, and B. Lutz. 2004. The endogenous cannabinoid system protects against colonic inflammation. J. Clin. Invest. 113: 1202-1209. (Pubitemid 38544105)
10. Karsak, M., E. Gaffal, R. Date, L. Wang-Eckhardt, J. Rehnelt, S. Petrosino, K. Starowicz, R. Steuder, E. Schlicker, B. Cravatt, et al. 2007. Attenuation of allergic contact dermatitis through the endocannabinoid system. Science 316: 1494-1497. (Pubitemid 46906619)
11. Piomelli, D. 2003. The molecular logic of endocannabinoid signalling. Nat. Rev. Neurosci. 4: 873-884. (Pubitemid 37351427)
12. Klein, T. W. 2005. Cannabinoid-based drugs as anti-inflammatory therapeutics. Nat. Rev. Immunol. 5: 400-411. (Pubitemid 40685989)
13. Matsuda, L. A., S. J. Lolait, M. J. Brownstein, A. C. Young, and T. I. Bonner. 1990. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346: 561-564.
14. Zimmer, A., A. M. Zimmer, A. G. Hohmann, M. Herkenham, and T. I. Bonner. 1999. Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proc. Natl. Acad. Sci. USA 96: 5780-5785. (Pubitemid 29234695)
15. Marsicano, G., C. T. Wotjak, S. C. Azad, T. Bisogno, G. Rammes, M. G. Cascio, H. Hermann, J. Tang, C. Hofmann, W. Zieglgansberger, et al. 2002. The endogenous cannabinoid system controls extinction of aversive memories. Nature 418: 530-534. (Pubitemid 34851398)
16. Marsicano, G., S. Goodenough, K. Monory, H. Hermann, M. Eder, A. Cannich, S. C. Azad, M. G. Cascio, S. O. Gutiérrez, M. van der Stelt, et al. 2003. CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science 302: 84-88. (Pubitemid 37210691)
17. Maccarrone, M., M. Di Rienzo, N. Battista, V. Gasperi, P. Guerrieri, A. Rossi, and A. Finazzi-Agro. 2003. The endocannabinoid system in human keratinocytes. Evidence that anandamide inhibits epidermal differentiation through CB1 receptor-dependent inhibition of protein kinase C, activation protein-1, and transglutaminase. J. Biol. Chem. 278: 33896-33903. (Pubitemid 37553223)
18. Paradisi, A., N. Pasquariello, D. Barcaroli, and M. Maccarrone. 2008. Anandamide regulates keratinocyte differentiation by inducing DNA methylation in a CB1 receptor-dependent manner. J. Biol. Chem. 283: 6005-6012.
19. Agarwal, N., P. Pacher, I. Tegeder, F. Amaya, C. E. Constantin, G. J. Brenner, T. Rubino, C. W. Michalski, G. Marsicano, K. Monory, et al. 2007. Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors. Nat. Neurosci. 10: 870-879. (Pubitemid 47013432)
20. Vassar, R., M. Rosenberg, S. Ross, A. Tyner, and E. Fuchs. 1989. Tissue-specific and differentiation-specific expression of a human K14 keratin gene in transgenic mice. Proc. Natl. Acad. Sci. USA 86: 1563-1567. (Pubitemid 19078943)
21. +CTL responses following gene gun immunization targeting the skin with intracutaneous injection of antigen-transduced dendritic cells. Eur. J. Cell Biol. 86: 817-826. (Pubitemid 350082192)
22. Lichti, U., J. Anders, and S. H. Yuspa. 2008. Isolation and short-term culture of primary keratinocytes, hair follicle populations and dermal cells from newborn mice and keratinocytes from adult mice for in vitro analysis and for grafting to immunodeficient mice. Nat. Protoc. 3: 799-810. (Pubitemid 351639024)
23. Kuhn, R., F. Schwenk, M. Aguet, and K. Rajewsky. 1995. Inducible gene targeting in mice. Science 269: 1427-1429.
24. Freedberg, I. M., M. Tomic-Canic, M. Komine, and M. Blumenberg. 2001. Keratins and the keratinocyte activation cycle. J. Invest. Dermatol. 116: 633-640. (Pubitemid 32467639)
25. Kaplan, D. H., B. Z. Igyártó, and A. A. Gaspari. 2012. Early immune events in the induction of allergic contact dermatitis. Nat. Rev. Immunol. 12: 114-124.
26. Van Damme, J., P. Proost, J. P. Lenaerts, and G. Opdenakker. 1992. Structural and functional identification of two human, tumor-derived monocyte chemotactic proteins (MCP-2 and MCP-3) belonging to the chemokine family. J. Exp. Med. 176: 59-65.
27. Biedermann, T., M. Kneilling, R. Mailhammer, K. Maier, C. A. Sander, G. Kollias, S. L. Kunkel, L. Hultner, and M. Rocken. 2000. Mast cells control neutrophil recruitment during T cell-mediated delayed-type hypersensitivity reactions through tumor necrosis factor and macrophage inflammatory protein 2. J. Exp. Med. 192: 1441-1452.
28. Matsushima, H., Y. Ogawa, T. Miyazaki, H. Tanaka, A. Nishibu, and A. Takashima. 2010. Intravital imaging of IL-1beta production in skin. J. Invest. Dermatol. 130: 1571-1580.
29. Klein, T. W., C. A. Newton, N. Nakachi, and H. Friedman. 2000. Delta 9-tetrahydrocannabinol treatment suppresses immunity and early IFN-gamma, IL-12, and IL-12 receptor beta 2 responses to Legionella pneumophila infection. J. Immunol. 164: 6461-6466. (Pubitemid 30408829)
30. Leonti, M., L. Casu, S. Raduner, F. Cottiglia, C. Floris, K. H. Altmann, and J. Gertsch. 2010. Falcarinol is a covalent cannabinoid CB1 receptor antagonist and induces pro-Allergic effects in skin. Biochem. Pharmacol. 79: 1815-1826.
31. Struyf, S., E. Van Collie, L. Paemen, W. Put, J. P. Lenaerts, P. Proost, G. Opdenakker, and J. Van Damme. 1998. Synergistic induction of MCP-1 and -2 by IL-1beta and interferons in fibroblasts and epithelial cells. J. Leukoc. Biol. 63: 364-372. (Pubitemid 28106851)
32. Zaidi, M. R., S. Davis, F. P. Noonan, C. Graff-Cherry, T. S. Hawley, R. L. Walker, L. Feigenbaum, E. Fuchs, L. Lyakh, H. A. Young, et al. 2011. Interferon-g links ultraviolet radiation to melanomagenesis in mice. Nature 469: 548-553.
33. + T(H)2 cells. Nat. Immunol. 12: 167-177.
34. Elias, P. M., Y. Hatano, and M. L. Williams. 2008. Basis for the barrier abnormality in atopic dermatitis: outside-inside-outside pathogenic mechanisms. J. Allergy Clin. Immunol. 121: 1337-1343.
35. Oka, S., J. Wakui, S. Ikeda, S. Yanagimoto, S. Kishimoto, M. Gokoh, M. Nasui, and T. J. Sugiura. 2006. Involvement of the cannabinoid CB2 receptor and its endogenous ligand 2-Arachidonoylglycerol in oxazolone-induced contact dermatitis in mice. J. Immunol. 177: 8796-8805. (Pubitemid 44893846)
36. Petrosino, S., L. Cristino, M. Karsak, E. Gaffal, N. Ueda, T. Tuting, T. Bisogno, D. De Filippis, A. D'Amico, C. Saturnino, et al. 2010. Protective role of palmitoylethanolamide in contact allergic dermatitis. Allergy 65: 698-711.
37. Ibrahim, M. M., F. Porreca, J. Lai, P. J. Albrecht, F. L. Rice, A. Khodorova, G. Davar, A. Makriyannis, T. W. Vanderah, H. P. Mata, and T. P. Malan, Jr. 2005. CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids. Proc. Natl. Acad. Sci. USA 102: 3093-3098. (Pubitemid 40299921)